Jyoti D. Patel

17.0k total citations · 4 hit papers
230 papers, 6.1k citations indexed

About

Jyoti D. Patel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jyoti D. Patel has authored 230 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Pulmonary and Respiratory Medicine, 157 papers in Oncology and 45 papers in Cancer Research. Recurrent topics in Jyoti D. Patel's work include Lung Cancer Treatments and Mutations (147 papers), Lung Cancer Research Studies (66 papers) and Lung Cancer Diagnosis and Treatment (49 papers). Jyoti D. Patel is often cited by papers focused on Lung Cancer Treatments and Mutations (147 papers), Lung Cancer Research Studies (66 papers) and Lung Cancer Diagnosis and Treatment (49 papers). Jyoti D. Patel collaborates with scholars based in United States, Germany and Spain. Jyoti D. Patel's co-authors include Mark G. Kris, Peter B. Bach, Vincent A. Miller, Robert T. Heelan, Philip Bonomi, William Pao, Maureen F. Zakowski, Lee M. Krug, Thomas A. Hensing and Christopher G. Azzoli and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jyoti D. Patel

215 papers receiving 6.0k citations

Hit Papers

Bronchioloalveolar Pathologic Subtype and Smoking History... 2004 2026 2011 2018 2004 2018 2013 2022 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
    2004 628 citations Mark G. Kris, Jyoti D. Patel et al. Journal of Clinical Oncology profile →
  2. Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
    2018 434 citations Jyoti D. Patel et al. Journal of Clinical Oncology profile →
  3. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
    2013 350 citations Jyoti D. Patel, Sylvia Adams et al. Journal of Clinical Oncology profile →
  4. Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A
    2022 128 citations Karen L. Reckamp, Mary W. Redman et al. Journal of Clinical Oncology profile →

Peers

Jyoti D. Patel
Thomas E. Stinchcombe United States
James Stevenson United States
Glenwood Goss Canada
Anne S. Tsao United States
Alessandro Morabito Italy
Kaoru Kubota Japan
Alan B. Sandler United States
Apar Kishor Ganti United States
Mark Vincent Canada
Petr Zatloukal Czechia
Thomas E. Stinchcombe United States
Jyoti D. Patel
Citations per year, relative to Jyoti D. Patel Jyoti D. Patel (= 1×) peers Thomas E. Stinchcombe

Countries citing papers authored by Jyoti D. Patel

Since Specialization
Citations

This map shows the geographic impact of Jyoti D. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyoti D. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyoti D. Patel more than expected).

Fields of papers citing papers by Jyoti D. Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jyoti D. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyoti D. Patel. The network helps show where Jyoti D. Patel may publish in the future.

Co-authorship network of co-authors of Jyoti D. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Jyoti D. Patel. A scholar is included among the top collaborators of Jyoti D. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyoti D. Patel. Jyoti D. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reck, Martin, Jyoti D. Patel, Jhanelle E. Gray, et al.. (2025). First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study. Journal of Thoracic Oncology. 21(3). 103509–103509.
3.
Patel, Jyoti D., James Stevenson, Hui Chen, et al.. (2024). EP.12H.01 A Phase 2 Study to Assess BDTX-1535, An Oral EGFR Inhibitor, in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 19(10). S657–S657. 2 indexed citations
4.
Ben‐Shachar, Rotem, Josephine Feliciano, Kyle A. Beauchamp, et al.. (2024). Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients With Advanced Non–Small Cell Lung Cancer. JAMA Network Open. 7(11). e2442970–e2442970. 5 indexed citations
5.
Gray, Janet, Joel W. Neal, Jyoti D. Patel, et al.. (2024). OA08.07 Sacituzumab Govitecan + Pembrolizumab + Carboplatin in 1L Metastatic Non-Small Cell Lung Cancer: The EVOKE-02 Study. Journal of Thoracic Oncology. 19(10). S27–S27. 3 indexed citations
6.
Liebovitz, David, et al.. (2024). Automated survivorship care plan generation using large language models.. Journal of Clinical Oncology. 42(16_suppl). e13595–e13595. 1 indexed citations
7.
Kim, Samuel S., David T. Cooke, Luis F. Tapias, et al.. (2024). The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-small Cell Lung Cancer. The Annals of Thoracic Surgery. 119(1). 16–33. 6 indexed citations
8.
Aggarwal, Charu, Yinjie Gao, Seung Won Hyun, et al.. (2023). Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy. JAMA Network Open. 6(5). e2311181–e2311181. 69 indexed citations
9.
Rotow, Julia, Jyoti D. Patel, Helena A. Yu, et al.. (2023). Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR -Mutant and RET Fusion-Positive Lung Cancers. Clinical Cancer Research. 29(16). 2979–2987. 26 indexed citations
10.
Vaidya, Riha, Joseph M. Unger, Katherine Minichiello, et al.. (2023). Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP). JCO Precision Oncology. 7(7). e2300218–e2300218. 1 indexed citations
11.
12.
Reckamp, Karen L., Mary W. Redman, Konstantin H. Dragnev, et al.. (2022). Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A. Journal of Clinical Oncology. 40(21). 2295–2307. 128 indexed citations breakdown →
13.
Boni, Valentina, Alexander Drilon, John F. Deeken, et al.. (2021). SO-29 Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset. Annals of Oncology. 32. S214–S215. 10 indexed citations
14.
Patel, Jyoti D., et al.. (2020). A homoeopathic approach in the treatment of gastritis. International Journal of Homoeopathic Sciences. 4(3). 37–40.
15.
Schnoll, Robert A., Frank T. Leone, Anna Veluz‐Wilkins, et al.. (2019). A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence. Psycho-Oncology. 28(3). 561–569. 28 indexed citations
16.
Simmons, John K., Aleksandra M. Michalowski, Wendy Dubois, et al.. (2017). Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. Molecular Cancer Therapeutics. 16(9). 2008–2021. 27 indexed citations
17.
Koshy, Matthew, Philip P. Connell, Everett E. Vokes, et al.. (2017). Impact of Cardiac Dose on Cardiac Events and Survival in Unresectable Lung Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 98(1). 247–247. 1 indexed citations
18.
Bahcall, Magda, Taebo Sim, Cloud P. Paweletz, et al.. (2016). Acquired MET D1228V Mutation and Resistance to MET Inhibition in Lung Cancer. Cancer Discovery. 6(12). 1334–1341. 114 indexed citations
19.
Vogelzang, Nicholas J., Sylvia Adams, Carol Aghajanian, et al.. (2011). Clinical Cancer Advances 2011: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Journal of Clinical Oncology. 30(1). 88–109. 68 indexed citations
20.
Patel, Jyoti D., et al.. (2010). Dystocia in Mare due to fetal Postural defect. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas E. Stinchcombe Breakdown of academic impact, for papers by James Stevenson Breakdown of academic impact, for papers by Glenwood Goss Breakdown of academic impact, for papers by Anne S. Tsao Breakdown of academic impact, for papers by Alessandro Morabito Breakdown of academic impact, for papers by Kaoru Kubota Breakdown of academic impact, for papers by Alan B. Sandler Breakdown of academic impact, for papers by Apar Kishor Ganti Breakdown of academic impact, for papers by Mark Vincent Breakdown of academic impact, for papers by Petr Zatloukal
Rankless by CCL
2026